Trials / Withdrawn
WithdrawnNCT03108690
Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Sara Thønnings · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study investigates whether Therapeutic Drug Monitoring (TDM) and continuous infusion (CI) of beta-lactam antibiotics optimises target concentrations in patients with bacteraemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Continuous infusion of beta-lactam antibiotics . | Beta-lactam antibiotic will be administered as continous infusion. |
| OTHER | Therapeutic drug monitoring of beta-lactam antibiotics. | Dosage of beta-lactam antibiotics will be adjusted according to serum concentration. |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2023-03-09
- Completion
- 2023-03-09
- First posted
- 2017-04-11
- Last updated
- 2023-03-29
Source: ClinicalTrials.gov record NCT03108690. Inclusion in this directory is not an endorsement.